LEADER 03917nam  22005895  450 
001 9910298295203321
005 20200702121532.0
010   $a1-4939-2553-9
024 7 $a10.1007/978-1-4939-2553-7
035   $a(CKB)3710000000377765
035   $a(EBL)2094433
035   $a(SSID)ssj0001465043
035   $a(PQKBManifestationID)11755342
035   $a(PQKBTitleCode)TC0001465043
035   $a(PQKBWorkID)11458342
035   $a(PQKB)11292012
035   $a(DE-He213)978-1-4939-2553-7
035   $a(MiAaPQ)EBC3108605
035   $a(MiAaPQ)EBC2094433
035   $a(Au-PeEL)EBL2094433
035   $a(OCoLC)905224071
035   $a(PPN)184889618
035   $a(EXLCZ)993710000000377765
100   $a20150317d2015      u|         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aTextbook of Personalized Medicine /$fby Kewal K. Jain
205   $a2nd ed. 2015.
210  1$aNew York, NY :$cSpringer New York :$cImprint: Humana,$d2015.
215   $a1 online resource (762 p.)
300   $aDescription based upon print version of record.
311   $a1-4939-2552-0 
320   $aIncludes bibliographical references at the end of each chapters and index.
327   $aBasic Aspects -- Molecular Diagnostics in Personalized Medicine -- Role of Biomarkers in Personalized Medicine -- Pharmacogenetics -- Pharmacogenomics -- Pharmacoproteomics.- Role of Metabolomics in Personalized Medicine -- Non-genomic Factors in the Development of Personalized Medicine -- Personalized Biological Therapies -- Personalized Therapy of Cancer -- Personalized Management of Infectious Diseases -- Personalized Management of Neurological Disorders -- Personalized Management of Psychiatric Disorders -- Personalized Management of Cardiovascular Disorders -- Personalized Management of Pulmonary Disorders -- Personalized Management of Genetic Disorders -- Personalized Approaches to Immune Disorders -- Personalized Approaches to Miscellaneous Problems in Healthcare.- Personalized Non-Pharmacological Therapies -- Development of Personalized Medicine.- Ethical Aspects of Personalized Medicine -- Regulatory Aspects of Personalized Medicine.- Economics of Personalized Medicine -- Future of Personalized Medicine.
330   $aAdvances in the technology used in personalized medicine and increased applications for clinical use have created a need for this expansion and revision of Kewal K. Jain?s Textbook of Personalized Medicine. As the first definitive work on this topic, this book reviews the fundamentals and development of personalized medicine and subsequent adoptions of the concepts by the biopharmaceutical industry and the medical profession. It also discusses examples of applications in key therapeutic areas, as well as ethical and regulatory issues, providing a concise and comprehensive source of reference for those involved in healthcare management, planning, and politics. Algorithms are included as a guide to those involved in the management of important diseases where decision-making is involved due to the multiple choices available. Textbook of Personalized Medicine, Second Edition will serve as a convenient source of information for physicians, scientists, decision makers in the biopharmaceutical and healthcare industries, and interested members of the public.
606   $aPharmacology
606   $aPharmacology/Toxicology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21007
615  0$aPharmacology.
615 14$aPharmacology/Toxicology.
676   $a610
676   $a615
700   $aJain$b Kewal K$4aut$4http://id.loc.gov/vocabulary/relators/aut$0766976
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910298295203321
996   $aTextbook of Personalized Medicine$92523016
997   $aUNINA